financetom
Business
financetom
/
Business
/
Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease
Jan 28, 2025 12:22 PM

02:53 PM EST, 01/28/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Tuesday the US Food and Drug Administration approved its Ozempic to reduce the risk of kidney failure, worsening kidney disease and death due to cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease.

Price: 86.01, Change: -1.50, Percent Change: -1.71

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved